Nektar Therapeutics (NKTR)
57.60
-1.18
(-2.01%)
USD |
NASDAQ |
Dec 10, 15:12
Nektar Therapeutics Market Cap: 996.51M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 891.57B |
| Amicus Therapeutics, Inc. | 3.048B |
| Regeneron Pharmaceuticals, Inc. | 75.72B |
| Rigel Pharmaceuticals, Inc. | 767.26M |
| Zevra Therapeutics, Inc. | 486.41M |
Market Cap Related Metrics
| PS Ratio | 59.39 |
| PEG Ratio | -0.0284 |
| Price to Book Value | 11.71 |
| Price | 57.60 |
| Earnings Yield | -7.91% |
| PEGY Ratio | -0.0284 |